Essential Hypertension
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
445
|
293
|
0.300 |
None |
|
0 |
|
|
|
Elevated mean arterial pressure
|
phenotype |
Cardiovascular Diseases
|
Finding
|
10
|
1
|
0.100 |
None |
|
0 |
|
|
|
Elevated systolic blood pressure
|
phenotype |
Cardiovascular Diseases
|
Finding
|
14
|
1
|
0.100 |
None |
|
0 |
|
|
|
Elevated diastolic blood pressure
|
phenotype |
Cardiovascular Diseases
|
Finding
|
14
|
1
|
0.100 |
None |
|
0 |
|
|
|
Schizophrenia and related disorders
|
group |
Mental Disorders
|
Disease or Syndrome
|
20
|
5
|
0.310 |
None |
1.000 |
1 |
|
2010 |
2010 |
Thrombus
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
46
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Encephalopathy, Toxic
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Neurotoxicity Syndromes
|
group |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
34
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Toxic Encephalitis
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Thrombosis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
98
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Nephrosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
68
|
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Hepatoma, Morris
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
124
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Reperfusion Injury
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Injury or Poisoning
|
300
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Alloxan Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Streptozotocin Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Experimental Hepatoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
117
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Cholestasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
420
|
15
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Hormone measurement
|
group |
|
Laboratory Procedure
|
51
|
134
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
ASSAY FOR TACROLIMUS
|
phenotype |
|
Laboratory Procedure
|
2
|
3
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Platelet Count measurement
|
phenotype |
|
Laboratory Procedure
|
265
|
457
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Malignant neoplasm of testis
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
253
|
31
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Acute leukemia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
639
|
50
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |